A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03407417|
Recruitment Status : Recruiting
First Posted : January 23, 2018
Last Update Posted : February 2, 2021
|Condition or disease||Intervention/treatment||Phase|
|Colo-rectal Cancer||Other: virtual technology - highly tailored Other: virtual technology - tailored minimally||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||4000 participants|
|Intervention Model:||Parallel Assignment|
|Masking Description:||Study Team will recruit an ethnically diverse sample of eligible patients (N = 3,000, 1,500 men, 1,500 women, evenly distributed across White, African-American, Hispanic/Latino) to complete the intervention|
|Official Title:||A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care|
|Actual Study Start Date :||November 8, 2018|
|Estimated Primary Completion Date :||February 2022|
|Estimated Study Completion Date :||February 2022|
Experimental: Fit Testing
Patients who self selected to receive FIT screening after interaction with the Application
Other: virtual technology - highly tailored
The app will first ask participants a short series of questions designed to assess their baseline risk for colon cancer. Highly tailored patient reminders will be customized using all 12 constructs.
Other Name: Virtual human application
Active Comparator: Non-FIT testing
Patients who elected not to have FIT testing after interaction with the application
Other: virtual technology - tailored minimally
The app will first ask participants a short series of questions designed to assess their baseline risk for colon cancer. Minimally tailored patient reminders will be customized using 4 randomly selected constructs.
Other Name: Standard tailored messaging
- Completion of initial FIT screening [ Time Frame: within the first 12 months ]Fecal immunochemical test is a screening test for colon cancer. It tests for hidden blood in the stool, which can be an early sign of cancer. FIT only detects human blood from the lower intestines.
- Completion of repeat Annual FIT screening [ Time Frame: up to 24 months ]Fecal immunochemical test is a screening test for colon cancer. It tests for hidden blood in the stool, which can be an early sign of cancer. FIT only detects human blood from the lower intestines.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03407417
|Contact: Janice Krieger, PhD||3522730240||JANICEKRIEGER@UFL.EDU|
|United States, Florida|
|University of Florida||Recruiting|
|Gainesville, Florida, United States, 32611|
|University of Florida||Not yet recruiting|
|Jacksonville, Florida, United States, 32208|
|Principal Investigator:||Janice Kreiger, PhD||University of Florida|